Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 53976 - 54000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Mitotane	Approved Investigational	COX4I1	1327	downregulated	Mitotane results in decreased expression of COX4I1 mRNA	16q24.1	A23401
Mitotane	Approved Investigational	CYP11A1	1583	downregulated	Mitotane results in decreased expression of CYP11A1 mRNA	15q24.1	A23402 A23403
Mitotane	Approved Investigational	CYP11B1	1584	upregulated	Mitotane results in increased expression of CYP11B1 mRNA	8q24.3	A23404 A23402
Mitotane	Approved Investigational	CYP17A1	1586	downregulated	Mitotane results in decreased expression of CYP17A1 mRNA	10q24.32	A23403
Mitotane	Approved Investigational	CYP21A2	1589	downregulated	Mitotane results in decreased expression of CYP21A2 mRNA	6p21.33	A23402 A23400
Mitotane	Approved Investigational	CYP3A4	1576	upregulated	Mitotane results in increased expression of CYP3A4 mRNA	7q22.1	A23405
Mitotane	Approved Investigational	GDF15	9518	upregulated	Mitotane results in increased expression of GDF15 mRNA	19p13.11	A23400
Mitotane	Approved Investigational	HSD3B1	3283	downregulated	Mitotane results in decreased expression of HSD3B1 mRNA	1p12	A23400
Mitotane	Approved Investigational	HSD3B2	3284	downregulated	Mitotane results in decreased expression of HSD3B2 mRNA	1p12	A23404 A23400
Mitotane	Approved Investigational	PRKAR1A	5573	downregulated	Mitotane results in decreased expression of PRKAR1A mRNA	17q24.2	A23403
Mitotane	Approved Investigational	RRM1	6240	upregulated	Mitotane results in increased expression of RRM1 mRNA	11p15.4	A23406
Mitotane	Approved Investigational	SERPINE2	5270	upregulated	Mitotane results in increased expression of SERPINE2 mRNA	2q36.1	A23400
Mitotane	Approved Investigational	STAR	6770	downregulated	Mitotane results in decreased expression of STAR mRNA	8p11.23	A23402
Mitotane	Approved Investigational	TGFB1	7040	downregulated	Mitotane results in decreased expression of TGFB1 mRNA	19q13.1	A23403
Mitotane	Approved Investigational	TRIB3	57761	upregulated	Mitotane results in increased expression of TRIB3 mRNA	20p13	A23400
Oxalic Acid	Experimental	CCL2	6347	upregulated	Oxalic Acid results in increased expression of CCL2 mRNA	17q12	A23407
Oxalic Acid	Experimental	CYBA	1535	upregulated	Oxalic Acid results in increased expression of CYBA mRNA	16q24.2	A23407
Oxalic Acid	Experimental	HAVCR1	26762	upregulated	Oxalic Acid results in increased expression of HAVCR1 mRNA	5q33.3	A23408
Oxalic Acid	Experimental	NCF1	653361	upregulated	Oxalic Acid results in increased expression of NCF1 mRNA	7q11.23	A23407
Oxalic Acid	Experimental	SPP1	6696	upregulated	Oxalic Acid results in increased expression of SPP1 mRNA	4q22.1	A23407
Oxaliplatin	Approved Investigational	AAMP	14	upregulated	oxaliplatin results in increased expression of AAMP mRNA	2q35	A23409
Oxaliplatin	Approved Investigational	ADA	100	downregulated	oxaliplatin results in decreased expression of ADA mRNA	20q13.12	A23409
Oxaliplatin	Approved Investigational	ADAM19	8728	upregulated	oxaliplatin results in increased expression of ADAM19 mRNA	5q33.3	A22638
Oxaliplatin	Approved Investigational	ALDOC	230	downregulated	oxaliplatin results in decreased expression of ALDOC mRNA	17q11.2	A23409
Oxaliplatin	Approved Investigational	ANKRD22	118932	upregulated	oxaliplatin results in increased expression of ANKRD22 mRNA	10q23.31	A22638

Displaying entries 53976 - 54000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability